Public Profile

Nordic Bioscience A/S

Nordic Bioscience A/S, headquartered in Denmark (DK), is a pioneering biotechnology company specialising in the development of innovative solutions for the healthcare industry. Founded in 2002, the company has established itself as a leader in biomarker research and diagnostics, focusing on areas such as fibrosis, osteoarthritis, and cardiovascular diseases. With a commitment to advancing personalised medicine, Nordic Bioscience offers unique products and services, including proprietary biomarker assays and clinical trial support. Their cutting-edge technologies are designed to enhance patient outcomes and streamline drug development processes. Recognised for its scientific excellence, Nordic Bioscience has achieved significant milestones, positioning itself as a trusted partner in the global biopharmaceutical landscape.

DitchCarbon Score

How does Nordic Bioscience A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Nordic Bioscience A/S's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Nordic Bioscience A/S's reported carbon emissions

Nordic Bioscience A/S, headquartered in Denmark (DK), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many organisations in the biotechnology sector are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprints. As Nordic Bioscience A/S continues to operate within this evolving industry context, it may consider establishing measurable climate commitments in the future to align with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nordic Bioscience A/S's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Nordic Bioscience A/S is headquartered in DK, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Nordic Bioscience A/S is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

SomaLogic, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 2 months ago
DitchCarbon Score

Perspectum Group plc

GB
Computer and related services (72)
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers